142 related articles for article (PubMed ID: 8612720)
1. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
Tertov VV; Bittolo-Bon G; Sobenin IA; Cazzolato G; Orekhov AN; Avogaro P
Exp Mol Pathol; 1995 Jun; 62(3):166-72. PubMed ID: 8612720
[TBL] [Abstract][Full Text] [Related]
2. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
[TBL] [Abstract][Full Text] [Related]
3. [Isolation of desialylated low density lipoproteins from the blood of patients with ischemic heart disease by affinity chromatography].
Tertov VV; Sobenin IA; Tonevitskiĭ AG; Orekhov AN
Biull Eksp Biol Med; 1990 Dec; 110(12):606-9. PubMed ID: 2083359
[TBL] [Abstract][Full Text] [Related]
4. Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation.
Tertov VV; Sobenin IA; Orekhov AN
Int J Tissue React; 1992; 14(4):155-62. PubMed ID: 1478792
[TBL] [Abstract][Full Text] [Related]
5. [Desialylated low density lipoproteins--atherogenic lipoproteins occurring in blood of patients with coronary atherosclerosis].
Mukhin DN; Tertov VV; Kacharava AG; Orekhov AN
Biull Eksp Biol Med; 1990 Aug; 110(8):138-40. PubMed ID: 2291955
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
Tertov VV; Orekhov AN
Exp Mol Pathol; 1997; 64(3):127-45. PubMed ID: 9439479
[TBL] [Abstract][Full Text] [Related]
7. Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.
Sobenin IA; Tertov VV; Orekhov AN
Int Angiol; 1994 Mar; 13(1):78-83. PubMed ID: 8077803
[TBL] [Abstract][Full Text] [Related]
8. Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein.
Tertov VV; Sobenin IA; Orekhov AN
Free Radic Res; 1996 Oct; 25(4):313-9. PubMed ID: 8889495
[TBL] [Abstract][Full Text] [Related]
9. Lipid composition of circulating multiple-modified low density lipoprotein.
Zakiev ER; Sukhorukov VN; Melnichenko AA; Sobenin IA; Ivanova EA; Orekhov AN
Lipids Health Dis; 2016 Aug; 15(1):134. PubMed ID: 27558696
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
[TBL] [Abstract][Full Text] [Related]
11. Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.
Orekhov AN; Tertov VV; Mukhin DN
Atherosclerosis; 1991 Feb; 86(2-3):153-61. PubMed ID: 1872910
[TBL] [Abstract][Full Text] [Related]
12. [Carbohydrate composition of native and desialylated low density lipoproteins in the plasma of patients with coronary atherosclerosis].
Tertov VV; Sobenin IA; Gevara Kh; Morrisett DD; Orekhov AN
Kardiologiia; 1992 Sep; 32(9-10):57-61. PubMed ID: 1287315
[TBL] [Abstract][Full Text] [Related]
13. Presence of a modified low density lipoprotein in humans.
Avogaro P; Bon GB; Cazzolato G
Arteriosclerosis; 1988; 8(1):79-87. PubMed ID: 3341993
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of low density lipoprotein isolated from circulating immune complexes.
Tertov VV; Sobenin IA; Orekhov AN; Jaakkola O; Solakivi T; Nikkari T
Atherosclerosis; 1996 May; 122(2):191-9. PubMed ID: 8769682
[TBL] [Abstract][Full Text] [Related]
15. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells.
Sobenin IA; Tertov VV; Koschinsky T; Bünting CE; Slavina ES; Dedov II; Orekhov AN
Atherosclerosis; 1993 Apr; 100(1):41-54. PubMed ID: 8318062
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
Kacharava AG; Tertov VV; Orekhov AN
Ann Med; 1993 Dec; 25(6):551-5. PubMed ID: 8292305
[TBL] [Abstract][Full Text] [Related]
17. Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay.
Tertov VV; Sobenin IA; Orekhov AN
Clin Chem; 1995 Jul; 41(7):1018-21. PubMed ID: 7600681
[TBL] [Abstract][Full Text] [Related]
18. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients.
Orekhov AN; Tertov VV; Mukhin DN; Mikhailenko IA
Biochem Biophys Res Commun; 1989 Jul; 162(1):206-11. PubMed ID: 2751649
[TBL] [Abstract][Full Text] [Related]
19. Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography.
Tertov VV; Sobenin IA; Tonevitsky AG; Orekhov AN; Smirnov VN
Biochem Biophys Res Commun; 1990 Mar; 167(3):1122-7. PubMed ID: 2322261
[TBL] [Abstract][Full Text] [Related]
20. Atherogenic modified LDL in diabetes.
Sobenin IA; Tertov VV; Orekhov AN
Diabetes; 1996 Jul; 45 Suppl 3():S35-9. PubMed ID: 8674887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
